TDACU Translational Development Acquisition Corp.
Price Chart
Executive Summary
Translational Development Acquisition Corp. (TDACU) filed definitive additional proxy soliciting materials (DEFA14A) for an extraordinary general meeting on June 17, 2026. The meeting seeks shareholder approval to extend the deadline to complete a business combination from June 24, 2026 to June 24, 2027, via up to twelve one-month extensions, each requiring a deposit of the lesser of $200,000 or $0.03 per outstanding public share into the trust account. The board recommends a vote 'FOR' all three proposals: the Extension Amendment, the Trust Agreement Amendment, and the Adjournment Proposal.
Actionable Insight
Monitor the shareholder vote outcome on June 17, 2026. Approval of the extension proposals provides the SPAC up to 12 additional months to find a target, reducing near-term liquidation risk. Failure to pass could force dissolution and trust distribution. The stock price may trade near trust value (~$10) with minimal premium given the extension uncertainty.
Key Facts
- Extraordinary general meeting scheduled for June 17, 2026 at 10:00 a.m. Eastern Time (virtual).
- Proposal 1: Extension Amendment to extend the combination period up to 12 months to June 24, 2027.
- Proposal 2: Trust Agreement Amendment to allow monthly extensions with a deposit of the lesser of $200,000 or $0.03 per public share.
- Proposal 3: Adjournment Proposal to allow further solicitation if votes are insufficient.
- Board unanimously recommends a vote 'FOR' all three proposals.
- Deadline to vote electronically is 11:59 p.m. Eastern Time on June 16, 2026.
Financial Impact
Extension payments of up to $200,000 per month (or $0.03 per share) for up to 12 months, funded via promissory notes, not cash from trust.
Risk Factors
- Shareholders may not approve the extension, leading to liquidation and return of trust proceeds.
- Repeated monthly extension payments could deplete sponsor resources if no deal is consummated.
- No identified business combination target disclosed; deal risk remains high.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-067648 |
| Document: 0001104659-26-067648-index-headers.html | 0001104659-26-067648 |
| Document: 0001104659-26-067648-index.html | 0001104659-26-067648 |
| Document: 0001104659-26-067648.txt | 0001104659-26-067648 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
21d ago
|
DEFA14A
| $11.98 $11.15 | ▼ −6.93% | ▼ −4.40% | $11.99 (+0.08%) |
|
May 11, 2026
5w ago
|
10-K/A
| $10.44 $10.44 | · 0.00% | ▼ −0.09% | $11.99 (−14.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access